BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced that on May 12, 2023, its Board of Directors approved a new share repurchase authorization for the purchase of up to $500 million of the Company’s common stock over a two-year period commencing on May 15, 2023. The share repurchase authorization permits shares to be repurchased... Read more
Emissions Reduction Equates to 623,000 Cars* Driven for One Year Xylem’s Latest Sustainability Report Tracks Broad Progress in Solving Global Water Challenges Xylem achieves key sustainability goal to enable customers to reduce CO2e footprint three years ahead of schedule 88% of electricity used at Read more
Notice Concerning Dividends from Surplus | IR News | News Release ＆ IR News | Investor Relations Read more
Takara Bio Group Formulated “Medium-Term Management Plan 2026” | IR News | News Release ＆ IR News | Investor Relations Read more
Consolidated Financial Results for the Fiscal Year Ended March 31, 2023 (Under Japanese GAAP) | IR News | News Release ＆ IR News | Investor Relations Read more
Q1 2023 revenues of $685.3 million, up 15.2% year-over-year (yoy); organic revenue up 17.6% yoy Q1 2023 GAAP EPS $0.52; non-GAAP EPS $0.64, up 30.6% yoy Bruker increases FY 2023 guidance for revenue to $2.83-$2.88 billion and for non-GAAP EPS to $2.55-$2.60; implies revenue growth to 12%-14%, and organic revenue growth of 9% – 11%... Read more
First-quarter revenue grew 14%, up 17% organically First-quarter earnings per share of $0.54 , up 20%; adjusted earnings per share of $0.72 , up 53% Raising full-year organic revenue growth guidance to 8% to 9%, from 4% to 6% Lifting full-year adjusted EPS guidance to $3.15 to $3.35 , from $3.00 to Read more
Global operations restored following ransomware incident Revenue of $794 million GAAP net loss per diluted share of $0.64 Non-GAAP net earnings per diluted share of $0.48 Operating cash flow of $37 million and free cash flow of $20 million ANDOVER, Mass., May 03, 2023 (GLOBE NEWSWIRE) — MKS Read more
WALTHAM, Mass.–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present at the BofA Securities 2023 Healthcare Conference on Wednesday, May 10, 2023 at 11:00 a.m. (EDT). You can access the webcast of the presentation via the Investors... Read more